Moolec Science (MLECW) Current Assets (2022 - 2025)
Moolec Science (MLECW) posted Current Assets of $31.2 million for Q2 2025, up 226.8% sequentially from $9.5 million in Q4 2024, and down 92.88% YoY from $438.2 million in Q2 2024.
Moolec Science (MLECW) Current Assets (2022 - 2025) Analysis & Trends
Moolec Science has reported Current Assets for 4 years, with the latest figure at $31.2 million in Q2 2025.
- Quarterly Current Assets fell 92.88% year-over-year to $31.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $31.2 million (down 92.88% YoY) and the FY2025 annual result came in at $31.2 million, down 92.88% from the prior year.
- Current Assets rose to $31.2 million in Q2 2025 per MLECW's latest filing, from $9.5 million in the prior quarter.
- Over five years, Current Assets peaked at $438.2 million in Q2 2024 and troughed at $1.1 million in Q2 2022.
- A 4-year average of $51.6 million and a median of $9.5 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets soared 4568.73% in 2023, then tumbled 92.88% in 2025.
- Over 4 years, Current Assets stood at $10.4 million in 2022, then sank by 65.97% to $3.6 million in 2023, then surged by 168.84% to $9.5 million in 2024, then soared by 226.8% to $31.2 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $31.2 million, $9.5 million, and $11.2 million for Q2 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 31.19 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 11.15 Mn |
| Jun 30, 2024 | 438.21 Mn |
| Mar 31, 2024 | 6.61 Mn |
| Dec 31, 2023 | 3.55 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 50.60 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 10.43 Mn |
| Jun 30, 2022 | 1.08 Mn |